-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Amyloidosis and Waldenström Macroglobulinemia

Program: Spotlight Sessions
Session: Plasma Cell Disorders Other Than Myeloma
Monday, December 7, 2015, 2:45 PM-4:15 PM
W314, Level 3 (Orange County Convention Center)

Steven P Treon, MD, PhD

Bing Center for WM, Dana Farber Cancer Institute, Boston, MA

Disclosures: Off Label Use: Carfilzomib will be discussed as treatment option in WM. Combination strategies with ibrutinib..

See more of: Plasma Cell Disorders Other Than Myeloma
See more of: Spotlight Sessions
<< Previous Presentation | Next Presentation